DTCP is set to exit video conferencing software developer BlueJeans Network which has agreed to an acquisition by Verizon Business reportedly sized at under $500m.

Telecoms innovation and management veteran Bill Payne has become science and technology lead at the Polsky Center for Entrepreneurship and Innovation.

Novo has backed automated molecule and material discovery business Kebotix, co-founded by former Harvard University professor Alán Aspuru-Guzik.

The flash storage system provider secured series C funding from investors including Siemens, Dell and Mellanox, valuing it at $1.2bn.

Long-term investors Johnson & Johnson Innovation, JJDC and Pfizer Ventures took part in a round that boosted the radiotherapy developer's overall funding to $264m.

The radiotherapy developer, which is exploiting UChicago research, has now raised $264m in funding overall.

The Baidu-backed advanced chemicals developer secured $11.4m in a series A round featuring Novo with a targeted close of $15m.

The traffic analysis-based cybersecurity software developer took its total funding to near $80m in a Liberty Global-backed series C round.

GV has contributed to the $30m in funding revealed by on-demand cloud network service Alkira when it emerged from stealth this week.

OSF Ventures invested $2m to bring the lung-imaging technology provider's latest round, which already included UnityPoint Health, to $13m.